Retatrutide, from Soma Pharmaceuticals , is gaining significant attention as a potential treatment for metabolic regulation. This innovative drug merges the mechanism of a GLP-1 receptor stimulant and a GIP receptor activator , intended to simply promote weight loss but also target underlying met